Meta-analysis of determinants of survival following treatment of recurrent hepatocellular carcinoma.

Erridge, S; Pucher, P H; Markar, S R; Malietzis, G; Athanasiou, T; Darzi, A; Sodergren, M H; Jiao, L R

Erridge, S; Pucher, P H; Markar, S R; Malietzis, G; Athanasiou, T; Darzi, A; Sodergren, M H; Jiao, L R.

Affiliation

Erridge S; Department of Surgery and Cancer, Imperial College London, London, UK.
Pucher PH; Department of Surgery and Cancer, Imperial College London, London, UK.
Markar SR; Department of Surgery and Cancer, Imperial College London, London, UK.
Malietzis G; Department of Surgery and Cancer, Imperial College London, London, UK.
Athanasiou T; Department of Surgery and Cancer, Imperial College London, London, UK.
Darzi A; Department of Surgery and Cancer, Imperial College London, London, UK.
Sodergren MH; Department of Surgery and Cancer, Imperial College London, London, UK.
Jiao LR; Department of Surgery and Cancer, Imperial College London, London, UK.

Br J Surg ; 104(11): 1433-1442, 2017 Oct.

Article de En | MEDLINE | ID: mdl-28628947

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Carcinome hépatocellulaire / Tumeurs du foie / Récidive tumorale locale Type d'étude: Guideline / Observational_studies / Prognostic_studies / Systematic_reviews Limites: Humans Langue: En Journal: Br J Surg Année: 2017 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google